<
Print this article

Piramal – Biocatalysis: From academic curiosity to manufacturing mainstream – the emergence of enzymes as catalysts in API manufacture

Keywords:

e-version image

Click HERE to download the PDF version

 

 

The modern era of pharmaceuticals, based on synthetic compounds rather than natural extracts, emerged around the middle of the 20th century. Subsequently, the vast majority of pharmaceutical active ingredients have been synthesised using reactive stoichiometric reagents or simple catalysts such as metals or strong acids. Although the role of enzymes as catalysts in biological systems has been known since the second half of the 19th century, until quite recently their application in pharmaceutical synthesis had been restricted to a few niche applications such as the hydroxylation of steroids.


There are multiple reasons why enzymes were previously considered unsuitable for pharmaceutical synthesis, the primary ones being 

  • that the availability of enzymes was limited ...
...


 

Teknoscienze publisher & event organiser
viale Brianza 22, 20127
Milano – Italy
info@teknoscienze.com
Tel +39 02 26809375

 

 

Subscribe now